EGFR and lung carcinoma: Furthermore, survival curve analysis of all INCAN lung carcinoma patients with EGFR-non-mutated status identified a better overall survival index (statistically significant at p≤0.005) with lower MEOX2 and GLI-1 protein expression levels (p=0.122 and p=0.002, respectively) (Figure 9C).